Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Licenses Long QT Syndrome Test to Aussie Services Provider

NEW YORK (GenomeWeb News) - Clinical Data's PGxHealth division has inked a sub-license agreement with Australia’s Victorian Clinical Genetics Services for a test that is aimed at diagnosing a deadly heart disorder.
 
Under the non-exclusive agreement, VCGS, a subsidiary of the Murdoch Children's Research Institute, will use the PGxHealth diagnostic to test for familial long QT syndrome in Australia and in New Zealand.
 
LQTS is an inherited disorder in heart rhythm that predisposes patients to sudden fainting spells, dizziness, palpitations, seizures, and sudden death.
 
According to PGxHealth, the test can help determine whether patients are at risk of LQTS, aid diagnosis of the syndrome, and possibly guide treatment options for those who have exhibited symptoms.
 
Financial terms of the agreement were not provided.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.